SNSE SCHEDULE 13G/A: SEC filing
StemPoint Capital LP and affiliated filers
Filed with the SEC on · accession 0001104659-26-096753
SNSE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
StemPoint Capital LP and affiliated filers filed a joint filing agreement as an amendment to their Schedule 13G regarding their passive ownership position in Faeth Therapeutics, Inc. The filing is an administrative exhibit confirming joint filing responsibilities.
Key details
✦ Ask GOAX AI about this filing — what it means for SNSE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SNSE?
Click hereFrequently asked questions
What did SNSE file with the SEC on Aug 14, 2026?
SNSE filed a SCHEDULE 13G/A (SEC filing). StemPoint Capital LP and affiliated filers filed a joint filing agreement as an amendment to their Schedule 13G regarding their passive ownership position in Faeth Therapeutics, Inc. The filing is an administrative exhibit confirming joint filing responsibilities.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other SNSE SEC filings
Get alerts when SNSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days